Results for “”

Entry Author Date Location
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
GHO Capital Raises Over $1bn, Eyes Biotech Outsourcing Services 12/04/19 National
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI 12/03/19 San Diego
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal 12/03/19 San Francisco
Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down 12/03/19 Seattle
Caraway Therapeutics Names Martin Williams as CEO 12/03/19 Boston
A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns 12/03/19 National
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer 12/03/19 National
Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy 12/02/19 San Diego
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator 12/02/19 Boston
Deep 6 AI Adds $17M To Advance Clinical Trial Recruitment Software 12/02/19 National
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO Says 11/29/19 National
AstraZeneca, Novoheart to Co-Develop New Heart Model 11/27/19 National
La Jolla Pharma’s Share Price Halves On Trial End, CEO Departure 11/26/19 San Diego
AI Startup Healx Looks to Find Repurposable Drugs for Rare Diseases 11/26/19 National
PhoenixMD Adds Seed Funding to Test Experimental Breast Cancer Drug 11/26/19 San Diego
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule 11/25/19 San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M 11/25/19 Boston
Five Questions With a16z’s Vijay Pande on AI and Making New Drugs 11/25/19 National
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M 11/21/19 Boston
Alnylam Gets Quick FDA OK for Second RNAi Rare Disease Drug 11/20/19 Boston
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow 11/20/19 San Francisco
Biopharma Execs Remain Optimistic Despite Political Headwinds 11/20/19 National
France-Based Tissium Boosts US Work After Closing €38.75M Series B 11/20/19 Boston
Myovant to Seek FDA OK on Pill to Treat Advanced Prostate Cancer 11/19/19 San Francisco
Reata Rakes In $505M to Advance Development of Two Rare Disease Drugs 11/19/19 National
Novo Ventures Commits $25M to Grow Discovery “Greenhouse” in Boston 11/19/19 Boston
With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite 11/18/19 New York
Page 2 of 1955 « previous page · next page »